scholarly article | Q13442814 |
P50 | author | Alexei Degterev | Q90349351 |
P2093 | author name string | Bakhos A Tannous | |
Jonas Nilsson | |||
Thomas Wurdinger | |||
Michael Whalen | |||
Christian E Badr | |||
Johanna M Niers | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule | Q24290576 | ||
The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors | Q24310559 | ||
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. | Q24314730 | ||
Subversion of cellular autophagosomal machinery by RNA viruses | Q24522711 | ||
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation | Q28199391 | ||
Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice | Q80391824 | ||
Phase 1 trial of Anvirzel in patients with refractory solid tumors | Q83956808 | ||
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death | Q28278883 | ||
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury | Q29616008 | ||
3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes | Q29617843 | ||
Mutant sodium channel for tumor therapy. | Q30481753 | ||
A highly sensitive assay for monitoring the secretory pathway and ER stress | Q33288966 | ||
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation | Q33418973 | ||
Functional drug screening assay reveals potential glioma therapeutics | Q33780121 | ||
Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. | Q33795121 | ||
Safety and antitumor activity of recombinant soluble Apo2 ligand | Q33855449 | ||
Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. | Q34098735 | ||
Targeting mTOR signaling for cancer therapy | Q34220084 | ||
Apo2L/TRAIL and its death and decoy receptors | Q34532325 | ||
Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. | Q34533000 | ||
Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform | Q34691557 | ||
Novel therapeutic applications of cardiac glycosides | Q34864765 | ||
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway | Q34910947 | ||
Caspase-independent cell death in T lymphocytes | Q35116688 | ||
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks | Q35743146 | ||
Autophagy in metazoans: cell survival in the land of plenty | Q36146937 | ||
The neurotoxic effects of prenatal cardiac glycoside exposure: a hypothesis. | Q36323107 | ||
The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas | Q36485266 | ||
New approaches to primary brain tumor treatment | Q36603850 | ||
Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme | Q36614009 | ||
A secreted luciferase for ex vivo monitoring of in vivo processes | Q37235465 | ||
Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 | ||
The late stages of autophagy: how does the end begin? | Q37474350 | ||
Towards novel paradigms for cancer therapy. | Q37799251 | ||
Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions | Q39569903 | ||
Gaussia luciferase variant for high-throughput functional screening applications | Q39816512 | ||
Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells | Q40008856 | ||
Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors | Q40268596 | ||
Down-regulation of c-FLIP contributes to the sensitization effect of 3,3'-diindolylmethane on TRAIL-induced apoptosis in cancer cells. | Q40336857 | ||
Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model | Q40508031 | ||
Intracellular ATP levels determine cell death fate by apoptosis or necrosis. | Q41110278 | ||
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis | Q41115305 | ||
Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells | Q41510979 | ||
Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death | Q41717170 | ||
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. | Q41972615 | ||
A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. | Q44717221 | ||
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo | Q48548442 | ||
Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors. | Q55471801 | ||
P433 | issue | 11 | |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 1213-1224 | |
P577 | publication date | 2011-07-13 | |
P1433 | published in | Neuro-Oncology | Q15724471 |
P1476 | title | Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway | |
P478 | volume | 13 |
Q39420743 | Assays to Monitor Autophagy Progression in Cell Cultures. |
Q36627144 | Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis |
Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
Q34998829 | Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons |
Q61804315 | Computational drug repurposing for inflammatory bowel disease using genetic information |
Q28386608 | Evaluating the cancer therapeutic potential of cardiac glycosides |
Q21996341 | Guidelines for the use and interpretation of assays for monitoring autophagy |
Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
Q42577813 | Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme |
Q36784375 | Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma |
Q36905850 | Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair |
Q28535626 | Multiplex cytological profiling assay to measure diverse cellular states |
Q45682609 | Protein-protein interaction network analysis in chronic obstructive pulmonary disease |
Q39198894 | Regulatory effects of autophagy on spermatogenesis |
Q28537942 | Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines |
Q35679830 | Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy |
Q37028654 | Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. |
Q36953575 | Targeting cancer cells with the natural compound obtusaquinone. |
Q91726670 | Targeting β2 subunit of Na+/K+-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca2 |
Q50977546 | The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. |
Q86927793 | The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact |
Q58790027 | URI knockdown induces autophagic flux in gastric cancer cells |
Search more.